I am woman, hear me tweet! Social Media’s role in healthcare never better exemplified

Posted September 16, 2010 by William Stone
Categories: best practices, Business, healthcare, Marketing, Social Media

For years my colleague, Leigh Fazzina, who operates a Philadelphia-based healthcare communications consultancy, has touted the powerful role that social media can and should play in addressing ones’ health. A few days ago, she found herself in a situation to practice what she preaches.

Leigh was in the second leg of a triathlon on an unfamiliar wooded trail in Connecticut when she realized that she had made a wrong turn and had wandered off the correct path. With the sun waning, Leigh began to ride quicker in an effort to emerge from the woods before darkness overtook her. That’s when her front tire snagged on an exposed root, sending Leigh flying over the handlebars and down a slope. The bike tumbled after and landed on top of her.

In Leigh’s own words, “I was hyperventilating a bit, coughing, dry heaving, spitting up dirt, shaking, going into a semi shock and slightly panicking. My helmet hit so hard it was dented and flew off my head. The water bottle was crushed like a car had hit it and my bike looked like a Mack Truck hit it. I thought to myself, ‘How on earth did I just survive this?’”

Leigh yelled for help to no avail. After 20 minutes, she mustered up the strength to crawl over to her bike pack and retrieve her BlackBerry. This deep in the woods she was unable to get a strong enough signal to make an outgoing call, but it seemed as though her internet was working.

“I’ve had a serious injury and NEED Help! Can someone please call Winding Trails in Farmington, CT tell them I’m stuck bike crash in woods,” she tweeted at 7:05 p.m. on Tuesday, July 27, 2010. Within minutes, her network of over 1,000 connections was mobilized. From as far away as Italy and Oman, Fazzina’s Twitter friends read her plea for help; the Farmington Police Department received a call from a woman in California who read Leigh’s tweet.

Those of us in the professional communications industry have long pointed to social media platforms like Facebook and Twitter as the next frontier, and today you’d be hard put to find a business that doesn’t maintain a presence in the social media space. If you read my post THE DOCTOR IS INternet, you’ll see how many of us, including Leigh, have envisioned the role social media should play in the healthcare arena.

In this particular instance, social media’s beneficial role in one’s health was quite literal, but one should not discount the power of this communication tool in more typical interpretations of how it can improve the vitality of any organization—not simply those involved in healthcare delivery, but in all industries. Simply maintaining a Facebook page and Twitter account is not good enough. If your business is not currently using social media to mobilize its network, you might as well be stuck alone in the woods.

When the authorities arrived, they told Leigh “we are rescuing you from the Twitter call you did. Amazing! I guess that Twitter thing really works.” “Yep, it sure does,” Leigh replied.

 

William Stone is a Publishing and Marketing Consultant operating in Philadelphia, Pennsylvania, USA.

© William Stone, 2010. This content may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy and recording, so long as the author is notified via e-mail at wstone@WilliamStoneMarketing.com, and it is reproduced in whole, including this notice and the author’s biographic information above.

THE DOCTOR IS INternet: How the FDA Can Harness Social Media for Improved Patient Access to Treatments & Clinical Trials

Posted September 16, 2010 by William Stone
Categories: Clinical Trials - Patient Recruitment, healthcare, Social Media

Below is a letter that was written after Carmen Gonzalez (a Patient Clinical Trial Recruitment Strategist), Leigh Fazzina (Principal of Fazzina and Co. Communications Consulting), and I had a discussion about the role we see social media playing in promoting clinical research to potential subjects. After we composed the letter and forwarded it to parties we thought might be interested in its content, we found that many of our industry colleagues shared our sentiments. Several of them asked if they could sign the letter and together we submitted it to the U.S. Food and Drug Administration for consideration in their November 12 & 13, 2009, Advisory Committee Meeting hearing around the use of social media.

 ********************************************

Dear U.S. Food and Drug Administration:

There are many required activities to bring a new drug into the hands of the people who need it most. We believe the most important role is played by the drug development, clinical research, and patient recruitment process. To assist your agency’s Advisory Committee on crafting guidelines regarding Internet and social media tool usage to promote medical products1, we write to you to offer our recommendations. We also provide our thoughts concerning relevant topics that we feel are crucial in determining your policy decisions.

■  70 thousand clinical research studies are conducted at any given time.

■  An estimated 2% of the U.S. population participates in clinical research studies with more than 70% of those participating likely to do so again (CISCRP).

■  94% of the public recognize the importance of participating in clinical research in order to assist in the advancement of medical science. Yet 75% of the general public state they have little to no knowledge about the clinical research enterprise and the participation process (CenterWatch).

■  57% of Americans say they would be likely to participate in clinical research (CICSCRP).

■  Less than 5% of Americans know where to find information about relevant clinical trials (Getz, Tufts University)

Thus, the need to raise awareness of clinical trials among the public has never been more crucial. This demands that all media channels be harnessed, including traditional and digital means.

When drugs obtain FDA approval, marketing, advertising and communications initiatives are used to raise awareness of these new products. Likewise, at the beginning of the clinical research process, those same media initiatives are used by drug sponsors to help patients find treatment alternatives available in clinical studies. Every patient enrolled into a clinical study accelerates the advance of science and brings new viable treatments closer to reality.

We believe that raising the awareness of clinical research is an essential part of the drug marketing equation and is one that you must consider seriously. Why? Because more Americans are turning to the Internet to find medical information, so we need to help them find credible sources to make informed choices. Moreover, use of media, including social media, can serve as powerful agents to assist with patient enrollment, and ultimately in helping to bring new treatments to patients in need.

For more than 20 years, patient recruitment has been focused solely on attracting patients into clinical research studies by traditional marketing, advertising, and community outreach efforts. Our belief is that patients are best served by maximizing all communications channels, from traditional advertising to public relations to social media.

Historically, broadcast and print media have been used to great effect to enroll patients into clinical studies. With the advent of social media communication, we have witnessed an increasing use of this medium for patient recruitment purposes. Patients are finding it easier to search for alternative therapies online and gain access to treatments that they may not have been able to get or afford elsewhere. With 61% of American adults seeking medical help online, this trend will likely increase.2

Since the FDA currently allows for live television and radio interviews on scientific studies, clinical research, and FDA-approved drugs to be conducted with thought-leaders, we believe that a working model for communication in “real time” already exists. It is our recommendation that this model be adapted for crafting social media communications guidelines.

The rules governing Satellite Media Tours (SMTs) and Radio Media Tours (RMTs) provide a perfect example of the flexibility required for social media communications messaging while also adhering to FDA and HIPAA requirements. During TV or radio media interviews, the clinical study spokesperson must faithfully respect the core content requirements approved by the IRB, yet is given latitude to address the questioner appropriately. That is, the response of the study spokesperson is not pre-scripted because the question is unpredictable. However, the foundational content from which the spokesperson may cultivate his answer must align as closely as possible. This allowance for adaptive response provides a perfect balance between the need to honestly inform the public and still conform to the nuance of live conversation.

It is this same balance that we as practitioners within the social media realm seek from the FDA as it develops its guidelines regarding social media for patient recruitment. Sites such as Twitter, MySpace, Facebook, and others have instant messaging functionality, rendering their format akin to live Q&A sessions on radio or TV. The spontaneity of conversations, particularly on Twitter, requires an adaptive framework to achieve transparency and trust within these mediums from ordinary users. Simply sending IRB-approved promotional messages about a clinical trial without using the medium in ways typical of a common user raises suspicions of spamming. We ideally envision using this medium through messages that are faithful to IRB-approved core clinical study content, without the rigidity of a pre-fabricated response. That is, allowing adaptive messaging that conforms to IRB-approved content is crucial to communicating effectively and establishing transparency and authenticity. This approach means viewers won’t have to be subjected to canned messages and awkward responses, but can rely on a fluid conversation that honors social practice. Given the character limitations of certain mediums (e.g. Twitter’s 140-character text limit), we also see a need for flexibility in messaging through acronyms and abbreviated responses.

Using Twitter as an example, a typical user will “re-tweet” (or re-send) messages of others deemed newsworthy or interesting. Likewise, Twitter users “follow” other users online to stay attuned to their messages, just as Facebook and MySpace users adopt “friends” to become a part of their social network. These typical uses form the etiquette of participation. This behavior helps viewers on social media sites to intuitively determine that the message sender is a bona fide human and not an automated spammer. Hence, we think that alongside IRB-approved clinical study awareness messages, there should  be an allowance for non-study related messaging that includes news clips, resource links, re-tweets, and allows for the free exchange of conversation in much the same way that live radio and television Q&As are now managed by the FDA.

Accordingly, we encourage the FDA to expand its rules in the public relations area, specifically its SMT and RMT rules, to embrace the social media tent. We believe that the familiarity with these current rules among all stakeholders provides the necessary predictability and assurance that the public and communicators expect, while streamlining the FDA’s administrative responsibilities. All learning curves are avoided by applying tried-and-true rules already in place. We add that the success of the current regulatory framework for live television and radio is predominately because it is geared to their mediums. By expanding this long-standing rubric to social media, which shares its characteristics, the FDA can confidently predict a good fit. Protecting the safety and welfare of the public depends on rules that have proven their muster. We sincerely believe that the body of rules governing television and radio messaging for patient recruitment in a live forum meets this benchmark and should be adopted for social media.

As you consider the commercial market in developing your policies on social media usage, we encourage you to consider what is taking place on the clinical side. 87% of clinical trials should not be failing due to lack of patient recruitment. This number is too high and the toll on waiting patients seeking new treatments is unconscionable. Social media communications can help us close the gap between patients and the trials available for their participation. By developing concrete social media guidelines in the clinical research arena, your agency will bring expanded access of alternative treatments to patients across this country.

We are eager to make further recommendations to assist your mission and welcome your feedback. Thank you for your consideration.

Respectfully,

– William Stone, Sr. Healthcare Marketing Consultant

– Carmen R. Gonzalez, Patient Clinical Trial Recruitment Strategist

– Leigh Fazzina, Sr. Healthcare Communications|PR|Social Media Consultant

– John Benbrook, CEO, MMG

– Christine Pierre, CEO, RxTrials Inc.

– Deborah R. Tunick, RN, Director of Clinical Operations, Chesapeake Research Group, LLC

– Ira J. Gottlieb, DPM, Medical Director, Chesapeake Research Group, LLC

1.  We assume medical products to include prescription drugs for humans and animals, prescription biologics, and medical devices.

2.  Pew Internet & American Life Project, June 11, 2009; http://pewresearch.org/pubs/1248/americans-look-online-for-health-information

 

William Stone is a Publishing and Marketing Consultant operating in Philadelphia, Pennsylvania, USA.

© William Stone, 2010. This content may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy and recording, so long as the author is notified via e-mail at wstone@WilliamStoneMarketing.com, and it is reproduced in whole, including this notice and the author’s biographic information above.

Recommendations to the FDA on how they can harness social media for improved patient access to treatments and clinical trials

Posted November 5, 2009 by William Stone
Categories: Clinical Trials - Patient Recruitment

Below is a letter that several colleagues and I wrote to the US Food and Drug Administration that we plan on submitting for the November 12, 2009 Advisory Committee Meeting hearing. If you support the need for the FDA to include clinical research/patient recruitment in its social meda review, please join us in signing the letter by contacting us on Twitter by November 10, 2009:

  • William Stone           @William_Stone
  • Leigh Fazzina            @LeighFazzina
  • Carmen Gonzalez    @crgonzalez

 +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

Dear U.S. Food and Drug Administration:

There are many required activities to bring a new drug into the hands of the people who need it most. We believe the most important role is played by the drug development, clinical research, and patient recruitment process. To assist your agency’s Advisory Committee on crafting guidelines regarding Internet and social media tool usage to promote medical products[1], we write to you to offer our recommendations. We also provide our thoughts concerning relevant topics that we feel are crucial in determining your policy decisions.

Roughly 70 thousand clinical research studies are underway at any given time, while only 2% of the U.S. population participates in clinical trials. This has resulted in 87% of drugs never coming to market because patient recruitment deadlines fail, rendering clinical studies moot. The need to raise awareness of clinical trials among the public has never been more crucial. This demands that all media channels be harnessed, including traditional and digital means. 

When drugs obtain FDA approval, marketing, advertising and communications initiatives are used to raise awareness of these new products. Likewise, at the beginning of the clinical research process, those same media initiatives are used by drug sponsors to help patients find treatment alternatives available in clinical studies. Every patient enrolled into a clinical study accelerates the advance of science and brings new viable treatments closer to reality.

We believe that raising the awareness of clinical research is an essential part of the drug marketing equation and is one that you must consider seriously. Why? Because more Americans are turning to the Internet to find medical information, so we need to help them find credible sources to make informed choices. Moreover, use of media, including social media, can serve as powerful agents to assist with patient enrollment, and ultimately in helping to bring new treatments to patients in need.

For more than 20 years, patient recruitment has been focused solely on attracting patients into clinical research studies by traditional marketing, advertising, and community outreach efforts. Our belief is that patients are best served by maximizing all communications channels, from traditional advertising to public relations to social media.

Historically, broadcast and print media have been used to great effect to enroll patients into clinical studies. With the advent of social media communication, we have witnessed an increasing use of this medium for patient recruitment purposes. Patients are finding it easier to search for alternative therapies online and gain access to treatments that they may not have been able to get or afford elsewhere. With 61% of American adults seeking medical help online, this trend will likely increase.[2]

Since the FDA currently allows for live television and radio interviews on scientific studies, clinical research, and FDA-approved drugs to be conducted with thought-leaders, we believe that a working model for communication in “real time” already exists. It is our recommendation that this model be adapted for crafting social media communications guidelines.

The rules governing Satellite Media Tours (SMTs) and Radio Media Tours (RMTs) provide a perfect example of the flexibility required for social media communications messaging while also adhering to FDA and HIPAA requirements. During TV or radio media interviews, the clinical study spokesperson must faithfully respect the core content requirements approved by the IRB, yet is given latitude to address the questioner appropriately. That is, the response of the study spokesperson is not pre-scripted because the question is unpredictable. However, the foundational content from which the spokesperson may cultivate his answer must align as closely as possible. This allowance for adaptive response provides a perfect balance between the need to honestly inform the public and still conform to the nuance of live conversation.

It is this same balance that we as practitioners within the social media realm seek from the FDA as it develops its guidelines regarding social media for patient recruitment. Sites such as Twitter, MySpace, Facebook, and others have instant messaging functionality, rendering their format akin to live Q&A sessions on radio or TV. The spontaneity of conversations, particularly on Twitter, requires an adaptive framework to achieve transparency and trust within these mediums from ordinary users. Simply sending IRB-approved promotional messages about a clinical trial without using the medium in ways typical of a common user raises suspicions of spamming. We ideally envision using this medium through messages that are faithful to IRB-approved core clinical study content, without the rigidity of a pre-fabricated response. That is, allowing adaptive messaging that conforms to IRB-approved content is crucial to communicating effectively and establishing transparency and authenticity. This approach means viewers won’t have to be subjected to canned messages and awkward responses, but can rely on a fluid conversation that honors social practice. Given the character limitations of certain mediums (e.g. Twitter’s 140-character text limit), we also see a need for flexibility in messaging through acronyms and abbreviated responses.

Using Twitter as an example, a typical user will “re-tweet” (or re-send) messages of others deemed newsworthy or interesting. Likewise, Twitter users “follow” other users online to stay attuned to their messages, just as Facebook and MySpace users adopt “friends” to become a part of their social network. These typical uses form the etiquette of participation. This behavior helps viewers on social media sites to intuitively determine that the message sender is a bona fide human and not an automated spammer. Hence, we think that alongside IRB-approved clinical study awareness messages, there should  be an allowance for non-study related messaging that includes news clips, resource links, re-tweets, and allows for the free exchange of conversation in much the same way that live radio and television Q&As are now managed by the FDA.

Accordingly, we encourage the FDA to expand its rules in the public relations area, specifically its SMT and RMT rules, to embrace the social media tent. We believe that the familiarity with these current rules among all stakeholders provides the necessary predictability and assurance that the public and communicators expect, while streamlining the FDA’s administrative responsibilities. All learning curves are avoided by applying tried-and-true rules already in place. We add that the success of the current regulatory framework for live television and radio is predominately because it is geared to their mediums. By expanding this long-standing rubric to social media, which shares its characteristics, the FDA can confidently predict a good fit. Protecting the safety and welfare of the public depends on rules that have proven their muster. We sincerely believe that the body of rules governing television and radio messaging for patient recruitment in a live forum meets this benchmark and should be adopted for social media.

As you consider the commercial market in developing your policies on social media usage, we encourage you to consider what is taking place on the clinical side. 87% of clinical trials should not be failing due to lack of patient recruitment. This number is too high and the toll on waiting patients seeking new treatments is unconscionable. Social media communications can help us close the gap between patients and the trials available for their participation. By developing concrete social media guidelines in the clinical research arena, your agency will bring expanded access of alternative treatments to patients across this country.

We are eager to make further recommendations to assist your mission and welcome your feedback. Thank you for your consideration.

Respectfully,

– William Stone, Sr. Healthcare Marketing Consultant 

– Leigh Fazzina, Sr. Healthcare Communications|PR|Social Media Consultant

– Carmen R. Gonzalez, Patient Clinical Trial Recruitment Strategist

Can old dogs learn new tricks? Call center tactics, a psychological approach

Posted March 14, 2008 by William Stone
Categories: best practices, Business, Marketing

Tags: , , , , , , , , ,

Old dogs can learn new tricks, and should if one wishes to compete in today’s competitive consumer marketplace. But that doesn’t mean that you have to teach Fido to do back-flips or ride around in a leotard on a unicycle. Sometimes old tricks can be re-envisioned and given just enough flair to make them seem new again.

In the communications industry, one of these old tricks is a form of direct marketing that has a definite stigma attached to it:  Telemarketing.  If done right, however, telemarketing can prove to be a very effective weapon in your arsenal, and I’d argue that it should be a part of any organization’s marketing mix.  The problem is, most telemarketers are ill-equipped to deal with todays more savvy and time-crunched consumers, clients, and Association members. 

While direct mail formats are constantly being tested and revamped for optimal performance, the same cannot be said about most telemarketing scripts.  These scripts have become so universally familiar that both the rep and the prospect go on autopilot when these conversations commence.  This often means that the prospect is unwilling to give the rep’s message a fair consideration since the impression is “I’ve heard it all before.”

By utilizing a little good, old-fashioned psychology, however, this problem can be solved.  The concept is called neurolinguistic programming, which uses tactics such as embedded messages and vocal mirroring to achieve positive results.

In a nutshell, you need to create a script that strays from the traditional and far too often familiar style most commonly employed by customer service reps and telemarketers in order to adopt an approach that is engineered to be more psychologically persuasive.

An engineered telemarketing script gains its effectiveness by being subtle and, at times, even subliminal.  For instance, an engineered script would emphasize the embedded command “talk” to encourage the prospect to talk and allow the rep to continue with the presentation.

 An example would be the following:

“I’d like to talk with you about some / products that many customers to whom we talk tell us / they need to provide the most comprehensive and / current coverage in the industry. Do you have just a moment / more to talk with me about these beneficial products?

In the above example, I used the phrase “talk” three times, and implied the “need” to purchase the products.  I also inserted breathing marks ( / ) in the above passage. These marks are designed to prevent the Customer Service reps from breathing in expected places. 

Why interrupt normal breathing patterns?  Because most prospects decide whether they’re willing to consider the telemarketer’s message before they’ve even heard the sales pitch, and if they’re not interested, many of them will attempt to be polite by waiting for the familiar pause to indicate their decision.  Since the above script interrupts the pattern the prospect might expect, it enables the telephone rep to deliver the whole message without interruption. Moreover, it increases the likelihood that the prospect will be left alert and in need of closure. 

This is essentially the same concept behind a well-written teaser on an envelope.  It doesn’t matter how great an offer is if a prospect never learns of it.  The greatest challenge is to get a prospective customer to open your envelope or to listen to the whole phone conversation.  If successful, the likelihood that he or she will respond favorably to your offer increases tremendously.

The next trick is reserved for those prospects that are still on the fence and are reluctant to accept the offer. It’s called vocal mirroring.  The rationale behind this practice is essentially this:  when the speech patterns and metaphor use of a prospect is mimicked or “mirrored” by the rep, it positively influences the interaction. 

This fundamental principle of human interaction has previously been observed by countless psychologists.  For example, in a study by Van Baaren, Holland, Steenaert, and Van Knippenberg (2003), it was found that when waitresses mimicked the speech of their customers, they received higher tips than when they did not mimic their customers’ speech.

Now it should be understood that I’m not endorsing something as extreme as feigning an accent, but rather adopting similar patterns of communication.  For instance, if a reluctant prospect responds to your offer with “I just don’t see how this can help me,” the telemarketer can reply with “Give me just a moment more of your time and I’ll show you how it can help.”  The emphasis here is on the words “see” and “show”.  By adopting the prospect’s “sight” metaphor, the telemarketer increases the likelihood that the prospect will be willing to keep listening.

So is it possible to teach old dogs new tricks?  Absolutely.  Revitalize your marketing program with some of these psychologically-geared tactics, and take telemarketing out of the proverbial doghouse. 

Old dogs can learn new tricks, and should if one wishes to compete in today’s competitive consumer marketplace. But that doesn’t mean that you have to teach Fido to do back-flips or ride around in a leotard on a unicycle. Sometimes old tricks can be re-envisioned and given just enough flair to make them seem new again.

 

In the communications industry, one of these old tricks is a form of direct marketing that has a definite stigma attached to it:  Telemarketing.  If done right, however, telemarketing can prove to be a very effective weapon in your arsenal, and I’d argue that it should be a part of any organization’s marketing mix.  The problem is, most telemarketers are ill-equipped to deal with todays more savvy and time-crunched consumers, clients, and Association members. 

 

While direct mail formats are constantly being tested and revamped for optimal performance, the same cannot be said about most telemarketing scripts.  These scripts have become so universally familiar that both the rep and the prospect go on autopilot when these conversations commence.  This often means that the prospect is unwilling to give the rep’s message a fair consideration since the impression is “I’ve heard it all before.”

 

By utilizing a little good, old-fashioned psychology, however, this problem can be solved.  The concept is called neurolinguistic programming, which uses tactics such as embedded messages and vocal mirroring to achieve positive results.

 

In a nutshell, you need to create a script that strays from the traditional and far too often familiar style most commonly employed by customer service reps and telemarketers in order to adopt an approach that is engineered to be more psychologically persuasive.

 

An engineered telemarketing script gains its effectiveness by being subtle and, at times, even subliminal.  For instance, an engineered script would emphasize the embedded command “talk” to encourage the prospect to talk and allow the rep to continue with the presentation.

 

 An example would be the following:

 

“I’d like to talk with you about some / products that many customers to whom we talk tell us / they need to provide the most comprehensive and / current coverage in the industry. Do you have just a moment / more to talk with me about these beneficial products?

 

In the above example, I used the phrase “talk” three times, and implied the “need” to purchase the products.  I also inserted breathing marks ( / ) in the above passage. These marks are designed to prevent the Customer Service reps from breathing in expected places. 

 

Why interrupt normal breathing patterns?  Because most prospects decide whether they’re willing to consider the telemarketer’s message before they’ve even heard the sales pitch, and if they’re not interested, many of them will attempt to be polite by waiting for the familiar pause to indicate their decision.  Since the above script interrupts the pattern the prospect might expect, it enables the telephone rep to deliver the whole message without interruption. Moreover, it increases the likelihood that the prospect will be left alert and in need of closure. 

 

This is essentially the same concept behind a well-written teaser on an envelope.  It doesn’t matter how great an offer is if a prospect never learns of it.  The greatest challenge is to get a prospective customer to open your envelope or to listen to the whole phone conversation.  If successful, the likelihood that he or she will respond favorably to your offer increases tremendously.

 

The next trick is reserved for those prospects that are still on the fence and are reluctant to accept the offer. It’s called vocal mirroring.  The rationale behind this practice is essentially this:  when the speech patterns and metaphor use of a prospect is mimicked or “mirrored” by the rep, it positively influences the interaction. 

 

This fundamental principle of human interaction has previously been observed by countless psychologists.  For example, in a study by Van Baaren, Holland, Steenaert, and Van Knippenberg (2003), it was found that when waitresses mimicked the speech of their customers, they received higher tips than when they did not mimic their customers’ speech.

 

Now it should be understood that I’m not endorsing something as extreme as feigning an accent, but rather adopting similar patterns of communication.  For instance, if a reluctant prospect responds to your offer with “I just don’t see how this can help me,” the telemarketer can reply with “Give me just a moment more of your time and I’ll show you how it can help.”  The emphasis here is on the words “see” and “show”.  By adopting the prospect’s “sight” metaphor, the telemarketer increases the likelihood that the prospect will be willing to keep listening.

 

So is it possible to teach old dogs new tricks?  Absolutely.  Revitalize your marketing program with some of these psychologically-geared tactics, and take telemarketing out of the proverbial doghouse.

 

 

William Stone is a Publishing and Marketing Consultant operating in Philadelphia, Pennsylvania, USA.

 

 © William Stone, 2008. This content may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy and recording, so long as the author is notified via e-mail at wstone@WilliamStoneMarketing.com, and it is reproduced in whole, including this notice and the author’s biographic information above.

Singapore’s Savior from the Sea: A Tale of Sustainable Tourism

Posted March 11, 2008 by William Stone
Categories: best practices, Business, Marketing

Tags: , , , , , , , , , , ,

A case study in bigger, better marketing

Legend has it that long ago, when what is now Singapore was known as Temasek, a Javanese word meaning “sea”, a grand and majestic creature would rise from the depths of the ocean to protect the land and its people from peril. The beast, its plankton-entangled golden mane framing its lion head and scales that shimmered like a thousand pearls enrobing its fish-like tail, served as the area’s guardian for generations. Today its memory is sung in songs, recited in poems, and immortalized in statues. The most remarkable thing about this legend, however, is that it is not a legend at all, but a contemporary tale, only slightly more than forty years old.

As a professional marketer, I am enthralled by the story behind the story. The truth is that the Merlion was first envisioned in 1964 as an emblem for the Singapore Tourist Promotion Board (STPB). The Merlion was not born of the sea, but in the mind of a man, designed by Fraser Brunner, a member of the souvenir committee and a curator of the Van Kleef Aquarium.  

This manufactured icon was, nevertheless, beautiful in its poetic symmetry.  The Merlion’s head represents the creature (taken for a lion) that was spotted by Prince Sang Nila Utama of the Sri Vijaya Empire when he rediscovered the island in the 11th Century C.E. The prince later renamed the land “Singapura”, which in Sanskrit means “Lion City”.  The Merlion’s tail recalls the modest origin of the ancient city of Temasek, a small fishing village.  As one local Singaporean journalist eloquently put it in The Sunday Times on April 11, 1999, the Merlion “represents fusion of memory and imagination.”

Today, when countless tourists flock to modern Singapore to visit the five official Merlion statues sprinkled throughout the city-state, they are regaled with the modern Merlion “legend”.  It is rare that I have encountered such a sophisticated and successful promotional enterprise, and as a marketing professional I truly appreciate the immensity of the genius behind it. 

While the intention of the STPB was never to mislead prospective tourists into believing the Merlion legend that’s been popularized through such venues as the Merlion attraction on Sentosa Island, a Singaporean theme park, the fact remains that this innovative use of imagery, history, art, and folklore is an extremely successful promotional program of which the STPB should be proud.

Creating a sustainable tourist attraction with a close affinity to a fictional story has only successfully been accomplished a few times.  Possibly the best known instance of this was Walt Disney World’s erection of Cinderella’s Castle in 1971, which was a physical manifestation of the previously only imagined castle depicted in the 1950 movie (although, to be fair, I should point out that the castle’s design was heavily influenced by Neuschwanstein castle in Bavaria, Germany).  The animated film serves as an ongoing promotion for the theme park, just as the Merlion legend continuously supports and encourages tourism in Singapore.

Having been an independent republic for fewer than 45 years, Singapore is a young nation by anyone’s standards. Spanning only 272 square miles, it is tiny in terms of land mass, but Singapore’s sophisticated marketing savvy would seem to belie its youth and geographic dimensions.  This is one of the great success stories of the modern world of commerce, and why Singapore is recognized today as one of the most modern nations in Asia with such a strong economy. The lesson here is to think big, regardless of your size.  

Admittedly, sometimes big ideas require big bucks, so what are you to do if your budget is considerably smaller than your vision? The answer: Find ways to create new revenue streams with very little risk and almost no financial investment. Believe it or not, it is possible. Let me give you an example:

Establishing a publishing program in collaboration with an independent publishing house is a great way for Associations to produce non-dues revenue and provide optimal ROI. Even a small revenue stream from this enterprise would probably show up as positive income in a profit/loss analysis.

Here’s how it would work—under the publishing partnership arrangement, an Association:

■  provides content that can be adapted into books (e.g., a series of related annual meeting sessions, policy statements, guidelines, etc)
■  suggests new book topics, and
■  provides the collaborating publishing company access to potential authors and editors from its officers and members.

Many publishers will be more than happy to enter into a mutually beneficial arrangement like this where they produce marketable (and sellable) products based on content that the Association is consistently generating in return for providing the Association with a nominal royalty. The Association, in turn, is content with receiving access to an additional renewable revenue stream with minimal time and financial investments. It’s a win-win, and just one way of thinking bigger even when your budget is small.

Let the singular example of the Merlion inspire you to aspire to greater heights. Learn from Singapore’s model—think big and create your own sustainable revenue streams. The possibilities are as large as your imagination, as large as the “mythical” Merlion that teaches us that nothing is without reach, and no idea is too big to be realized.

 

William Stone is a Publishing and Marketing Consultant operating in Philadelphia, Pennsylvania, USA.

 

© William Stone, 2008. This content may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy and recording, so long as the author is notified via e-mail at wstone@WilliamStoneMarketing.com, and it is reproduced in whole, including this notice and the author’s biographic information above.